C000223413 Holdings — Equity Income Account

All 58 reported holdings of Equity Income Account (C000223413) by percentage of net assets, from the fund's latest SEC N-PORT filing.

Holding% of net assetsValue (USD)
Apple Inc4.43%$32.79M
Taiwan Semiconductor Manufacturing Co Ltd3.94%$29.20M
JPMorgan Chase & Co3.02%$22.38M
Morgan Stanley2.91%$21.58M
Microsoft Corp2.85%$21.10M
Costco Wholesale Corp2.83%$20.94M
Chubb Ltd2.81%$20.79M
DR Horton Inc2.80%$20.71M
Coca-Cola Co/The2.70%$19.98M
PNC Financial Services Group Inc/The2.67%$19.75M
Hilton Worldwide Holdings Inc2.47%$18.31M
Cummins Inc2.30%$17.01M
Trane Technologies PLC2.27%$16.83M
Broadcom Inc2.27%$16.79M
Principal Funds, Inc - Government Money Market Fund - Class R-62.23%$16.49M
Bank of America Corp2.22%$16.42M
Merck & Co Inc2.20%$16.33M
Parker-Hannifin Corp2.01%$14.90M
PACCAR Inc1.99%$14.77M
Marathon Petroleum Corp1.86%$13.80M
Monolithic Power Systems Inc1.84%$13.63M
Novartis AG1.84%$13.62M
Corteva Inc1.81%$13.43M
Procter & Gamble Co/The1.75%$12.95M
Prologis Inc1.75%$12.93M
Williams-Sonoma Inc1.72%$12.73M
Dick's Sporting Goods Inc1.67%$12.38M
EOG Resources Inc1.60%$11.83M
Reliance Inc1.59%$11.76M
Alphabet Inc - A Shares1.58%$11.74M
Equity LifeStyle Properties Inc1.54%$11.39M
Deere & Co1.52%$11.29M
NextEra Energy Inc1.50%$11.09M
Blackrock Inc1.48%$10.94M
Citigroup Inc1.47%$10.91M
HCA Healthcare Inc1.40%$10.34M
Enterprise Products Partners LP1.35%$9.97M
Abbott Laboratories1.34%$9.94M
Starbucks Corp1.33%$9.85M
Expeditors International of Washington Inc1.32%$9.80M
KKR & Co Inc1.18%$8.77M
AstraZeneca PLC1.15%$8.54M
T-Mobile US Inc1.15%$8.53M
Steris PLC1.08%$8.00M
Eli Lilly & Co1.07%$7.92M
Motorola Solutions Inc1.06%$7.87M
UnitedHealth Group Inc1.03%$7.60M
Sap SE1.01%$7.47M
Chevron Corp0.97%$7.21M
WEC Energy Group Inc0.94%$6.98M
Publicis Groupe SA0.93%$6.87M
Xcel Energy Inc0.92%$6.85M
Sempra0.70%$5.17M
Salesforce Inc0.59%$4.35M
Air Products and Chemicals Inc0.52%$3.88M
Fidelity National Financial Inc0.51%$3.76M
Nasdaq Inc0.50%$3.73M
Roche Holding AG0.40%$3.00M

C000223413 overview: performance, fees, allocation and SEC filings